Extensions

Patent Term and Family Analysis for U.S. Patent 12,171,916

As of May 13, 2026, an analysis of the prosecution history and legal status of U.S. Patent 12,171,916 ("the '916 patent") reveals the following details regarding its term, related applications, and patent family.

Application and Term Details:

• Application Number: 17/205,374
• Filing Date: March 18, 2021
• Priority Date: May 30, 2017
• Issue Date: December 24, 2024

Patent Term Adjustments (PTA) and Extensions (PTE):

A review of the information available for the '916 patent indicates that no Patent Term Adjustments or Patent Term Extensions have been granted. The patent's term is therefore calculated from its filing date.

Projected Expiration Date:

Based on the filing date of March 18, 2021, and the standard 20-year term for a utility patent, the projected expiration date for U.S. Patent 12,171,916 is March 18, 2041. The provided patent information indicates an adjusted expiration of January 7, 2040, but the standard calculation based on the filing date yields the 2041 date. The discrepancy may be due to terminal disclaimers or other factors not immediately apparent from the source data. For the purpose of this analysis, the standard expiration will be noted alongside the database's listed date.

Continuation and Divisional Applications:

The '916 patent is part of a chain of continuing applications that claim priority to an original application filed on May 30, 2017.

• Parent Application: The '916 patent is a continuation of U.S. Application No. 16/866,078 (now U.S. Patent 10,980,926), filed on May 4, 2020.
• Grandparent Application: U.S. Application No. 16/866,078 is itself a continuation of U.S. Application No. 15/608,183 (now U.S. Patent 10,758,652), filed on May 30, 2017.
• Child Applications: The '916 patent has subsequent continuation applications:
  • U.S. Application No. 17/943,410, filed September 13, 2022 (now U.S. Patent 11,738,124).
  • U.S. Application No. 18/955,269, filed November 21, 2024 (now U.S. Patent 12,324,873).

No divisional applications have been identified for this patent.

Patent Family Members:

U.S. Patent 12,171,916 is a member of a larger patent family, with applications and granted patents in numerous jurisdictions. Key international family members include:

• WIPO (PCT): WO2018222441A1
• Australia: AU2018275198C1
• Canada: CA3064883A1
• China: CN110799223B
• Europe: EP4600632A3
• Japan: JP7257336B2
• South Korea: KR102585128B1

The existence of this extensive patent family indicates a broad international strategy by the assignee, Haemonetics Corp, to protect this plasma collection technology.